Takeover Potential, page-7

First 7 Last

Share
Profile

Follow
givemethecash

6,555 Posts.

822

12/02/24

14:26

Post #: 72361402
Share

Originally posted by MrAdz: ↑

Because ASIC is a toothless tiger.

EOS has been a leaky boat for a very long time and a stock which has been subject to pump and dump.

To those that are saying " this is cheap". Well, may very well be so, but it is for a reason.

I used to say the same thing when it dropped at my first buy in price of around $6.00 and it dropped some. At around 3 I doubled my holdings, and watched it sink like a lead balloon.

All you have to do is look at the past management decisions that lead us to where we have been. From reckless stupid spending to the bloated management structure, creative accounting, lack of control over debts, false promises. They took the money they had and spent it all on a failed venture. The child of Ben Greene. The arrogant head of the company who surrounded himself with those like him.
The company has made the right steps into correcting the wrongs, but still has a long way to go. It was on a verge of going into administration, and still possibly can if a few wrong decisions are made.
Millions of revenue mean sweet F all. It is what is banked at the end of the day that will decide the future of EOS.

For the record, I still hold some.

Expand

yes you bought at $6 and we say current price is cheap, ie: way undervalued that means , so don't put words in other peoples mouths. Definitely over $1 soon but doubt you'll see $6. Happy days.

EOS Price at posting: $1.63 Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

First 7 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $2.72		Change 0.070(2.64%)		Mkt cap ! $521.9M

Open	High	Low	Value	Volume
$2.68	$2.78	$2.67	$2.299M	845.1K

Buyers (Bids)

No.	Vol.	Price($)
2	3076	$2.71

Sellers (Offers)

Price($)	Vol.	No.
$2.73	11718	8

View Market Depth

No.	Vol.	Price($)
10	11985	2.700
4	4446	2.690
6	25576	2.680
8	37790	2.670
6	25085	2.660

Price($)	Vol.	No.
2.720	976	3
2.730	10563	7
2.740	23110	7
2.750	30043	3
2.760	9552	2

Last trade - 13.10pm 27/06/2025 (20 minute delay)

EOS (ASX) Chart

Takeover Potential, page-7

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Australia’s gas crisis is here – and dying coal plants aren’t helping

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Takeover Potential, page-7

Top Stories

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Australia’s gas crisis is here – and dying coal plants aren’t helping

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News